Ascites, Malignant: Clinical Trials

1 trial for Ascites, Malignant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Ascites, Malignant: new trials by email Literature Review of Ascites, Malignant trials Research Report on Ascites, Malignant

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
zoledronic acid plus Sintilimab intraperitoneal injection - Cancer of Stomach, Adenocarcinoma, Ascites, Malignant
Phase 1 / Phase 2RecruitingQilu Hospital of Shandong University242024-09-122025-11-19

Narrower conditions

Adenocarcinoma (1)  ·  Ascites (1)  ·  Stomach Neoplasms (1)

Broader conditions

Carcinoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Stomach Diseases (1)

Interventions

Zoledronic Acid (1)

Sponsors

Qilu Hospital of Shandong University (1)

Countries

China (1)